These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

634 related items for PubMed ID: 18222349

  • 1. IgA glycosylation and IgA immune complexes in the pathogenesis of IgA nephropathy.
    Novak J, Julian BA, Tomana M, Mestecky J.
    Semin Nephrol; 2008 Jan; 28(1):78-87. PubMed ID: 18222349
    [Abstract] [Full Text] [Related]

  • 2. IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.
    Novak J, Moldoveanu Z, Renfrow MB, Yanagihara T, Suzuki H, Raska M, Hall S, Brown R, Huang WQ, Goepfert A, Kilian M, Poulsen K, Tomana M, Wyatt RJ, Julian BA, Mestecky J.
    Contrib Nephrol; 2007 Jan; 157():134-8. PubMed ID: 17495451
    [Abstract] [Full Text] [Related]

  • 3. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
    Novak J, Moldoveanu Z, Julian BA, Raska M, Wyatt RJ, Suzuki Y, Tomino Y, Gharavi AG, Mestecky J, Suzuki H.
    Adv Otorhinolaryngol; 2011 Jan; 72():60-3. PubMed ID: 21865691
    [Abstract] [Full Text] [Related]

  • 4. Recognition of galactose-deficient O-glycans in the hinge region of IgA1 by N-acetylgalactosamine-specific snail lectins: a comparative binding study.
    Gomes MM, Suzuki H, Brooks MT, Tomana M, Moldoveanu Z, Mestecky J, Julian BA, Novak J, Herr AB.
    Biochemistry; 2010 Jul 13; 49(27):5671-82. PubMed ID: 20507092
    [Abstract] [Full Text] [Related]

  • 5. Glycosylation of IgA1 and pathogenesis of IgA nephropathy.
    Novak J, Julian BA, Mestecky J, Renfrow MB.
    Semin Immunopathol; 2012 May 13; 34(3):365-82. PubMed ID: 22434325
    [Abstract] [Full Text] [Related]

  • 6. Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease.
    Reily C, Ueda H, Huang ZQ, Mestecky J, Julian BA, Willey CD, Novak J.
    J Immunol Res; 2014 May 13; 2014():197548. PubMed ID: 25152896
    [Abstract] [Full Text] [Related]

  • 7. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.
    Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J.
    J Clin Invest; 1999 Jul 13; 104(1):73-81. PubMed ID: 10393701
    [Abstract] [Full Text] [Related]

  • 8. Aberrant Glycosylation of the IgA1 Molecule in IgA Nephropathy.
    Novak J, Barratt J, Julian BA, Renfrow MB.
    Semin Nephrol; 2018 Sep 13; 38(5):461-476. PubMed ID: 30177018
    [Abstract] [Full Text] [Related]

  • 9. O-glycosylation of IgA1 and the pathogenesis of an autoimmune disease IgA nephropathy.
    Novak J, King RG, Yother J, Renfrow MB, Green TJ.
    Glycobiology; 2024 Sep 30; 34(11):. PubMed ID: 39095059
    [Abstract] [Full Text] [Related]

  • 10. Glucocorticoids Reduce Aberrant O-Glycosylation of IgA1 in IgA Nephropathy Patients.
    Kosztyu P, Hill M, Jemelkova J, Czernekova L, Kafkova LR, Hruby M, Matousovic K, Vondrak K, Zadrazil J, Sterzl I, Mestecky J, Raska M.
    Kidney Blood Press Res; 2018 Sep 30; 43(2):350-359. PubMed ID: 29529610
    [Abstract] [Full Text] [Related]

  • 11. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity.
    Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA, Chatham WW, Suzuki Y, Wyatt RJ, Moldoveanu Z, Lee JY, Robinson J, Tomana M, Tomino Y, Mestecky J, Novak J.
    J Clin Invest; 2009 Jun 30; 119(6):1668-77. PubMed ID: 19478457
    [Abstract] [Full Text] [Related]

  • 12. O- and N-Glycosylation of Serum Immunoglobulin A is Associated with IgA Nephropathy and Glomerular Function.
    Dotz V, Visconti A, Lomax-Browne HJ, Clerc F, Hipgrave Ederveen AL, Medjeral-Thomas NR, Cook HT, Pickering MC, Wuhrer M, Falchi M.
    J Am Soc Nephrol; 2021 Oct 30; 32(10):2455-2465. PubMed ID: 34127537
    [Abstract] [Full Text] [Related]

  • 13. Role of aberrant glycosylation of IgA1 molecules in the pathogenesis of IgA nephropathy.
    Mestecky J, Tomana M, Moldoveanu Z, Julian BA, Suzuki H, Matousovic K, Renfrow MB, Novak L, Wyatt RJ, Novak J.
    Kidney Blood Press Res; 2008 Oct 30; 31(1):29-37. PubMed ID: 18182777
    [Abstract] [Full Text] [Related]

  • 14. The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy.
    Barratt J, Smith AC, Feehally J.
    Nephrology (Carlton); 2007 Jun 30; 12(3):275-84. PubMed ID: 17498123
    [Abstract] [Full Text] [Related]

  • 15. Progress in molecular and genetic studies of IgA nephropathy.
    Novak J, Julian BA, Tomana M, Mesteck J.
    J Clin Immunol; 2001 Sep 30; 21(5):310-27. PubMed ID: 11720004
    [Abstract] [Full Text] [Related]

  • 16. IgA nephropathy: an update.
    Julian BA, Novak J.
    Curr Opin Nephrol Hypertens; 2004 Mar 30; 13(2):171-9. PubMed ID: 15202611
    [Abstract] [Full Text] [Related]

  • 17. Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.
    Zhao YF, Zhu L, Liu LJ, Shi SF, Lv JC, Zhang H.
    BMC Nephrol; 2017 Sep 29; 18(1):301. PubMed ID: 28969604
    [Abstract] [Full Text] [Related]

  • 18. IgA nephropathy: molecular mechanisms of the disease.
    Mestecky J, Raska M, Julian BA, Gharavi AG, Renfrow MB, Moldoveanu Z, Novak L, Matousovic K, Novak J.
    Annu Rev Pathol; 2013 Jan 24; 8():217-40. PubMed ID: 23092188
    [Abstract] [Full Text] [Related]

  • 19. [IgA1 aberrant glycosylation in the pathogenesis of IgA nephropathy: an overivew].
    Xie L, Wang L, Huang J, Fan J.
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Feb 24; 27(1):227-30. PubMed ID: 20337060
    [Abstract] [Full Text] [Related]

  • 20. Aberrantly glycosylated IgA1 as a factor in the pathogenesis of IgA nephropathy.
    Tanaka M, Seki G, Someya T, Nagata M, Fujita T.
    Clin Dev Immunol; 2011 Feb 24; 2011():470803. PubMed ID: 21318178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.